HIF1A and myopia: Bridging molecular insights (e.g., hypoxia-HIF-1α-MMP-2 axis) with innovations like gene editing is essential to curb myopia progression, necessitating prioritized research on multiple pathways interaction and translational trials to advance precision ocular therapies.